p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells

Genes and Development

Volumn 13, Issue 13, 1999, Pages 1742-1753

  Kolluri, Siva Kumar ^a   Weiss, Carsten ^a   Koff, Andrew ^b   Göttlicher, Martin ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cell cycle; Cyclin dependent kinase inhibitors; Dioxins; Fetal thymus; mRNA induction; PAS proteins

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR; DIOXIN; MESSENGER RNA; PROTEIN P27; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FETUS; GENETIC TRANSCRIPTION; HEPATOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS;

ANIMALIA;

EID: 0033166447     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.13.1742     Document Type: Article

References (61)

1. Bartek, J., J. Bartkova, and J. Lukas. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell. Biol. 8: 805-814.
2. Bauman, J.W., T.L. Goldsworthy, C.S. Dunn, and T.R. Fox. 1995. Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy. Cell Prolif. 28: 437-451.
3. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: Many actors in search of a plot. Cell 83: 851-857.
4. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
5. Burbach, K.M., A. Poland, and C.A. Bradfield. 1992. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. 89: 8185-8189.
6. Carmeliet, P., Y. Dor, J.M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, C.J. Koch, P. Ratcliffe, L. Moons, R.K. Jain, D. Collen, and E. Keshet. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490.
7. Coats, S., P. Whyte, M.L. Fero, S. Lacy, G. Chung, E. Randel, E. Firpo, and J.M. Roberts. 1999. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr. Biol. 9: 163-173.
8. Crews, S.T. 1998. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes & Dev. 12: 607-620.
9. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
10. Dong, L., Q. Ma, and J.P. Whitlock, Jr. 1996. DNA binding by the heterodimeric Ah receptor. Relationship to dioxin-induced CYP1A1 transcription in vivo. J. Biol. Chem. 271: 7942-7948.
11. Dunlap, J.C. 1998. Common threads in eukaryotic circadian systems. Curr. Opin. Genet. Dev. 8: 400-406.
12. Ema, M., K. Sogawa, N. Watanabe, Y. Chujoh, N. Matsushita, O. Gotoh, Y. Funae, and Y. Fujii-Kuriyama. 1992. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184: 246-253.
13. Enan, E. and F. Matsumura. 1995. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49: 249-261.
14. Fernandez-Salguero, P.M., D.M. Hilbert, S. Rudikoff, J.M. Ward, and F.J. Gonzalez. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140: 173-179.
15. Fero, M.L., M. Rivkin, M. Tasch, P. Porter, C.E. Carow, E. Firpo, K. Polyak, L.H. Tsai, V. Broudy, R.M. Perlmutter, K. Kaushansky, and J.M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733-744.
16. Fero, M.L., E. Randel, K.E. Gurley, J.M. Roberts, and C.J. Kemp. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396: 177-180.
17. Ge, N.L. and C.J. Elferink. 1998. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J. Biol. Chem. 273: 22708-22713.
18. Göttlicher, M. and F.J. Wiebel. 1991. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes unbalanced growth in 5L rat hepatoma cells. Toxicol. Appl. Pharmacol. 111: 496-503.
19. Göttlicher, M., S. Heck, and P. Herrlich. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76: 480-489.
20. Greenberg, M.E. and E.B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433-438.
21. Heim, R., A.B. Cubitt, and R.Y. Tsien. 1995. Improved green fluorescence. Nature 373: 663-664.
22. Hengst, L. and S.I. Reed. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861-1864.
23. Hoffman, E.S., L. Passoni, T. Crompton, T.M. Leu, D.G. Schatz, A. Koff, M.J. Owen, and A.C. Hayday. 1996. Productive T-cell receptor β-chain gene rearrangement: Coincident regulation of cell cycle and clonality during development in vivo. Genes & Dev. 10: 948-962.
24. Holcomb, M. and S. Safe. 1994. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 82: 43-47.
25. Huff, J., G. Lucier, and A. Tritscher. 1994. Carcinogenicity of TCDD: Experimental, mechanistic, and epidemiologic evidence. Annu. Rev. Pharmacol. Toxicol. 34: 343-372.
26. Hushka, D.R. and W.F. Greenlee. 1995. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes. Mutat. Res. 333: 89-99.
27. Kiyokawa, H., R.D. Kineman, K.O. Manova-Todorova, V.C. Soares, E.S. Hoffman, M. Ono, D. Khanam, A.C. Hayday, L.A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85: 721-732.
28. Kociba, R.J., D.G. Keyes, J.E. Beyer, R.M. Carreon, C.E. Wade, D.A. Dittenber, R.P. Kalnins, L.E. Frauson, C.N. Park, S.D. Barnard, R.A. Hummel, and C.G. Humiston. 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46: 279-303.
29. Kwon, T.K. and A.A. Nordin. 1998. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor. Oncogene 16: 755-762.
30. Kwon, T.K., J.E. Nagel, M.A. Buchholz, and A.A. Nordin. 1996. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene 180: 113-120.
31. La Baer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes & Dev. 11: 847-862.
32. Lahvis, G.P. and C.A. Bradfield. 1998. Ahr null alleles: Distinctive or different? Biochem. Pharmacol. 56: 781-787.
33. Lai, Z.W., C. Hundeiker, E. Gleichmann, and C. Esser. 1997. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 52: 30-37.
34. Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell. Biol. 7: 773-780.
35. Liu, J., W.M. Flanagan, J.A. Drazba, M.L. Estes, G.H. Barnett, T. Haqqi, S. Kondo, and B.P. Barna. 1997. The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation. J. Immunol. 159: 812-819.
36. Loda, M., B. Cukor, S.W. Tam, P. Lavin, M. Fiorentino, G.F. Draetta, J.M. Jessup, and M. Pagano. 1997. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3: 231-234.
37. Luo, Y., S.O. Marx, H. Kiyokawa, A. Koff, J. Massagué, and A.R. Marks. 1996. Rapamycin resistance tied to defective regulation of p27Kip1. Mol. Cell. Biol. 16: 6744-6751.
38. Mangelsdorf, D.J. and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850.
39. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14: 2066-2076.
40. Migliaccio, A., D. Piccolo, G. Castoria, M. Di Domenico, A. Bilancio, M. Lombardi, W. Gong, M. Beato, and F. Auricchio. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17: 2008-2018.
41. Mimura, J., M. Ema, K. Sogawa, and Y. Fujii-Kuriyama. 1999. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes & Dev. 13: 20-25.
42. Morgan, D.O. 1995. Principles of CDK regulation. Nature 374: 131-134.
43. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D.Y. Loh, and K. Nakayama. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.
44. Nebert, D.W., A. Puga, and V. Vasiliou. 1993. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N.Y. Acad. Sci. 685: 624-640.
45. Nordeen, S.K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6: 454-458.
46. Pagano, M., S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P.R. Yew, G.F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685.
47. Pitot, H.C., T. Goldsworthy, H.A. Campbell, and A. Poland. 1980. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40: 3616-3620.
48. Poellinger, L., M. Göttlicher, and J.A. Gustafsson. 1992. The dioxin and peroxisome proliferator-activated receptors: Nuclear receptors in search of endogenous ligands. Trends Pharmacol. Sci. 13: 241-245.
49. Poland, A. and J.C. Knutson. 1982. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22: 517-554.
50. Polyak, K., M.H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst, and J. Massagué. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
51. Schmidt, J.V. and C.A. Bradfield. 1996. Ah receptor signaling pathways. Ann. Rev. Cell. Dev. Biol. 12: 55-89.
52. Sewall, C.H. and G.W. Lucier. 1995. Receptor-mediated events and the evaluation of the Environmental Protection Agency (EPA) of dioxin risks. Mutat. Res. 333: 111-122.
53. Sherr, C.J. and J.M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
54. Staples, J.E., F.G. Murante, N.C. Fiore, T.A. Gasiewicz, and A.E. Silverstone. 1998. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J. Immunol. 160: 3844-3854.
55. Steeg, P.S. and J.S. Abrams. 1997. Cancer prognostics: Past, present and p27. Nat. Med. 3: 152-154.
56. Sutter, T.R., K. Guzman, K.M. Dold, and W.F. Greenlee. 1991. Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1b. Science 254: 415-418.
57. Swanson, H.I., W.K. Chan, and C.A. Bradfield. 1995. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem. 270: 26292-26302.
58. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
59. Uren, A., J. Jakus, J.F. de Mora, A. Yeudall, E. Santos, S. Gutkind, and M.A. Heidaran. 1997. Carboxyl-terminal domain of p27Kip1 activates CDC2. J. Biol. Chem. 272: 21669-21672.
60. Weiss, C., S.K. Kolluri, F. Kiefer, and M. Göttlicher. 1996. Complementation of Ah receptor deficiency in hepatoma cells: Negative feedback regulation and cell cycle control by the Ah receptor. Exp. Cell Res. 226: 154-163.
61. Zuniga-Pflücker, J.C. and M.J. Lenardo. 1996. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8: 215-224.